Pfizer Eyes IPO of Glaxo Consumer Venture in 3 to 4 Years
The Pfizer Inc. Research and Development Center stands in Cambridge, Massachusetts, U.S. (Photographer: Scott Eisen/Bloomberg)

Pfizer Eyes IPO of Glaxo Consumer Venture in 3 to 4 Years

(Bloomberg) -- Pfizer Inc. is planning an initial public offering of its consumer-health joint venture with GlaxoSmithKline Plc in three to four years as the two drugmakers turn back toward the lab.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.